advertisement

Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages 

Chapter 1: Missed Signals: Uncovering the Hidden Clues of GHD

3 chapters
0.50 credits
30 Minutes
Play All
CME/CE
ReachMD Healthcare Image
Media formats available:
Details
Program chapters
Presenters
Related
  • Overview

    Join Dr. Aristides Maniatis for this Patient-Clinician Connection, a case-based activity that explores the full spectrum of care in Growth Hormone Deficiency. Through real patient and caregiver dialogues, this program teaches clinicians how to identify early signs of GHD, make accurate diagnoses, navigate pediatric-to-adult care transitions, and manage the switch from daily to long-acting growth hormone therapy. Grounded in real-life experiences and expert insights, this activity delivers practical strategies for fostering patient-centered care and improving outcomes across every stage of the GHD journey

  • Disclosure of Relevant Financial Relationships

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Chair:
    Aristides Maniatis, MD
    Pediatric Endocrinologist
    Rocky Mountain Pediatric Endocrinology 
    Centennial, CO

    Dr. Manitatis has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
    Advisor/Consultant: Ascendis, Novo Nordisk, and Pfizer
    Contracted Researcher: Ascendis, Novo Nordisk, and Pfizer

    Caregivers/Patient: 

    Meagan Broeckert
    GHD Caregiver
    Division Consultant GHD
    The Magic Foundation

    Meagan Broeckert has no relevant relationships to disclose.  

    Kari Hosack
    GHD Caregiver

    Kari Hosack has no relevant relationships to disclose.  

    Sam Watson
    GHD Patient

    Sam Watson has no relevant relationships to disclose.  

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has no relevant relationships to disclose. 
    • Parul Yadav, MD has no relevant relationships to disclose. 
    • Brian P. McDonough, MD, FAAFP has no relevant relationships to disclose.  
  • Learning Objectives

    Upon completion of this activity, learners should be better able to:

    • Develop strategies to improve the timely diagnosis of growth hormone deficiency (GHD) in both pediatric and adult patients. 
    • Design standardized protocols to enhance the management and quality of life of patients with GHD transitioning from pediatric to adult care, ensuring treatment continuity. 
    • Employ evidence-based practices for transitioning from daily growth hormone therapy to LAGH, including appropriate IGF-I monitoring in order to optimize therapeutic outcomes.  
  • Target Audience

    This activity has been designed to meet the educational needs of endocrinologists and pediatricians as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with Growth Hormone Disorder (GHD).  

  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and MAGIC Foundation. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 0.5AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Global Learning Collaborative (GLC) designates this activity for 0.5 nursing contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity. 

    Global Learning Collaborative (GLC)/AXIS Medical Education designates this activity for 0.5 contact hour(s)/0.05 CEUs of pharmacy contact hour(s). 
     
    The Universal Activity Number for this program is JA0006235-9999-25-083-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).  

     Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit(s). Approval is valid until August 5, 2026. PAs should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)


    Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.
     

  • Commercial Support

    This activity is supported by an independent educational grant from Novo Nordisk Pharmaceuticals, Inc. 

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site. 

    Reproduction Prohibited 

    Reproduction of this materialis not permitted without written permission from the copyright owner.  

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Register

We're glad to see you're enjoying Medtelligence…
but how about a more personalized experience?

Register for free